Our team of professionals are trained to conduct clinical trials for people who want to quit smoking.
Our trials test medications, behavioral approaches and various combinations of both in an attempt to find the most effective smoking cessation treatment. Our staff is also trained to conduct behavioral counseling.
The DUAL Study
The DUAL Study is a research study for cigarette smokers. The research study explores the potential of reducing smokers’ addiction to combustible cigarettes by reducing the nicotine content of tobacco. Study participants will also use e-cigarettes to model real world environments where e-cigarette use is growing. No research drug will be given, but you will be asked to use reduced nicotine cigarettes and an e-cigarette during the course of this study.
The purpose of this research study is:
- To gather information on the number of reduced nicotine cigarettes smoked per day
- To see at what point smokers can first detect nicotine and when smokers can detect a drop in nicotine
- To determine if e-cigarette use is related to the dual use of combustible cigarettes
- Between 21-65 years old
- No intention of quitting smoking in the next 90 days
- Smokes on average 4 days a week over the past year
- Willing to use reduced nicotine cigarettes and an e-cigarette, both provided by Rose Research
- Not currently diagnosed with any serious medical conditions
- On a daily basis, does NOT use chewing tobacco, cigars, pipes, hookahs, or e-cigarettes
- Has not used nicotine replacement therapy or other smoking cessation product in the last 30 days
- Has a smartphone with data and text capabilities
The RECON Study
The RECON study is a research study for cigarette smokers who want to switch to e-cigarettes. The purpose of this research study is to see if using an e-cigarette right before smoking helps to satisfy your craving for a cigarette and helps you switch to using only an e-cigarette.
- Between the age of 21-65
- Desire to switch from combustible cigarettes to e-cigarettes
- Currently smoke 10 or more cigarettes per day
- Able to pass a urine drug test
- No current serious medical conditions
- No use of other tobacco products in the last 14 days (including cigars, pipes, hookahs, e-cigarettes, or nicotine replacement therapy)
- You will receive $25 for completing Study Visit 1
- You will receive $75 for each completed visit; Study Visit 2 through Study Visit 7
- You will receive $5 a day for responding to text messages. In order to receive compensation, you will need to answer all of questions before you receive your next text message.
The EVAR Study
The purpose of this research study is to see if using an e-cigarette with varenicline (also called Chantix) helps you switch to using only an e-cigarette.
- Between the age of 21-65
- Desire to switch to an e-cigarette
- Willingness to take study medications as directed
- Currently smoke 10 or more cigarettes per day
- Able to pass a urine drug test
- No current serious medical conditions
- No use of other tobacco products in the last 14 days (including cigars, pipes, hookahs, e-cigarettes, or nicotine replacement therapy.)
- You will receive $25 for completing Study Visit 1
- You will receive $75 for each completed visit; Study Visit 2 through Study Visit 7 ($450 total)
- You will receive $5 a day for responding to text messages. In order to receive compensation, you will need to answer all of the questions before you receive your next text message.
The BUZONE Study
The BUZONE Study is a research study for cigarette smokers who want to switch to e-cigarettes. The purpose of this research study is to see if using an e-cigarette in combination with two medications (bupropion and zonisamide) helps you switch to using only an e-cigarette. Zonisamide is a drug approved by the United States Food and Drug Administration (FDA) for treatment of seizures. Bupropion (also known as Zyban) is a drug approved by the FDA for use as an aid to quit smoking.
SIGN-UP
For Future Studies
Fill out our form below for more information
Participant information is maintained in a volunteer database system and retained for future studies as they become available. Pertinent information is confidentially kept on file to aid in selecting highly qualified candidates for research studies.
* These fields are required.
Why should I participate?
Participants may gain access to new research treatments before they are widely available.
Additionally, participants are compensated for their time and receive study-related products and medications at no cost. You may be among the first to benefit if the approach being studied is found to be helpful.
